EP 1358323 A2 20031105 - REGULATORS OF APOPTOSIS
Title (en)
REGULATORS OF APOPTOSIS
Title (de)
APOPTOSEREGULATOREN
Title (fr)
REGULATEURS DE L'APOPTOSE
Publication
Application
Priority
- US 0117581 W 20010530
- US 20940700 P 20000601
- US 25032600 P 20001130
Abstract (en)
[origin: WO0192527A2] The invention provides human apoptosis regulators (APRG) and polynucleotides which identify and encode APRG. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of APRG.
IPC 1-7
C12N 15/12; C07K 14/47; C07K 16/18; G01N 33/68; G01N 33/53; A61K 38/17; C12Q 1/68
IPC 8 full level
G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 49/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 1/18 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 7/00 (2006.01); A61P 7/06 (2006.01); A61P 7/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/02 (2006.01); A61P 13/08 (2006.01); A61P 13/12 (2006.01); A61P 15/00 (2006.01); A61P 15/08 (2006.01); A61P 15/10 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/04 (2006.01); A61P 19/06 (2006.01); A61P 21/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 33/00 (2006.01); A61P 33/02 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); C12S 3/14 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 1/18 (2017.12); A61P 3/10 (2017.12); A61P 5/14 (2017.12); A61P 7/00 (2017.12); A61P 7/06 (2017.12); A61P 7/08 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/02 (2017.12); A61P 13/08 (2017.12); A61P 13/12 (2017.12); A61P 15/00 (2017.12); A61P 15/08 (2017.12); A61P 15/10 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/04 (2017.12); A61P 19/06 (2017.12); A61P 21/00 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 33/00 (2017.12); A61P 33/02 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/02 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 14/4747 (2013.01); C07K 16/18 (2013.01); A61K 38/00 (2013.01); C12Q 1/6876 (2013.01)
Citation (search report)
See references of WO 0192527A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0192527 A2 20011206; WO 0192527 A3 20030814; AU 7506301 A 20011211; CA 2409311 A1 20011206; EP 1358323 A2 20031105; JP 2004507225 A 20040311
DOCDB simple family (application)
US 0117581 W 20010530; AU 7506301 A 20010530; CA 2409311 A 20010530; EP 01941734 A 20010530; JP 2002500719 A 20010530